Health Sciences Authority of Singapore (HSA) Pharmacovigilance Journey

Overview

HSA is the national regulator of health products in Singapore. The Vigilance and Compliance Branch (VCB) of HSA ensures that health products used in Singapore continue to be safe through the administration of pharmacovigilance activities and post-market surveillance measures. Our pharmacovigilance (PV) journey started from humble beginnings in 1993, and has brought us to where we are today, an internationally recognised regulatory authority that uses strong scientific basis for decisions and innovativeness in its regulatory approaches.